5 Shares to Beat George Osborne
LONDON -- It's that time of year again. Every six months now, with the budget and the autumn statement, the financial press speculates on measures that will hit the pockets of the prudent at the expense of the profligate.
This time around, the fear is that on Wednesday the Chancellor will either reduce the total tax-free amount that can be contributed into a pension each year from its current 50,000 pounds -- a measure that would hit relatively few -- or remove higher-rate tax relief on pension contributions altogether. That would hurt many more.
The threats to pension relief could just be political stage-management, but they are plausible. If you're a higher-rate taxpayer planning to make contributions into your pension, it may be worth doing so before Wednesday.
That means moving fast. But online SIPP providers make the process simple and quick. And in any case, whether pension relief is changed or not, it's sensible for most people to save through tax-efficient vehicles such as SIPPs and ISAs.
What to invest in? Here's my pick of five shares to make an instant portfolio. I think it's better than a traditional tracker fund -- I'll explain why later.
Pick 1: Vodafone
The mobile-phone operator is in a sector that has taken on the characteristics of a utility; ownership of a mobile phone is seen by many as a necessity, if not a human right. Vodafone's shares yield 6%, thanks to a prodigious cash machine and its booming 45% U.S. associate. It's investing to grow its data and emerging-market revenue, which will support a growing dividend. The share dropped recently after its Southern European businesses were hit by the euro crisis (the sector isn't wholly insensitive to macroeconomics), but for me that created a buying opportunity.
Pick 2: GlaxoSmithKline
GlaxoSmithKline is a well-run company in a classic defensive sector. While pharmaceutical companies are generally struggling to replenish drug patent pipelines, GSK has used its scale to invest heavily in research and development while also shrewdly diversifying into over-the-counter medicines and building a strong emerging-market business. Yielding 5.5%, it's also a generous dividend payer.
Pick 3: Unilever
Consumer staples is another defensive sector. I'm still cautious about the downside risk of the euro debacle, which puts a defensive bias on my stock-picking. But Unilever has a strong emerging-markets presence, which provides a platform for growth. It's better-positioned than rival Reckitt Benckiser. On a price-to-earnings ratio of 19, it's expensive, but the 3.25% yield makes for a sound long-term investment.
Pick 4: British American Tobacco
Tobacco is another classic defensive sector. While the industry has been slightly on the back foot with the Australian government's measures to enforce the sale of cigarettes in plain packaging, it would be premature to forecast the industry's decline. Again, there is growth in emerging markets, and the industry is investing to develop safer and smokeless products. The hunt for safe dividends has made tobacco stocks expensive, so British American Tobacco is trading on a P/E of 16, but the yield of 4% is safe.
Pick 5: Royal Dutch Shell
Oil and gas is not a classic defensive sector, but a play on the oil price is no bad thing. Royal Dutch Shell is a financially strong company with good diversification by geography and product. It has a strong position in liquid natural gas and is a major player in U.S. shale gas. That business has suffered as prices have been affected by the glut of discoveries, but for me it's a good long-term position. Shell's P/E of eight and yield of 5% are attractive.
Of course, I could make a case for lots of other shares, but I think these are five sound picks, and I hope my thought process is informative. Why am I picking individual stocks rather than a tracker? Trackers are fine if you know what you're getting, but they don't necessarily offer the diversification you might expect. For example, an FTSE 100 tracker would have half of its exposure in just three sectors: oil and gas, mining, and banks. That's certainly not a concentration I want at the moment.
So stock-picking can be a safer strategy. If you're looking for ideas on stock-picking, you could do much worse than to follow one of the U.K.'s top experts: Neil Woodford, who runs Invesco Perpetual's Income and High Income funds. For nine years, from 2000 to 2008, he outperformed the FTSE All-Share index. And in 2011, his funds returned double the index.
Woodford has substantial holdings in some of the stocks I've mentioned. To find out which, and to discover more of his investing style, you can download this free and newly updated report from the Motley Fool: "8 Shares Held By Britain's Super-Investor." Simply click here to get a copy without obligation.
Tony owns shares in Vodafone, GlaxoSmithKline, Unilever, Reckitt Benckiser, BATS, and Shell.
The article 5 Shares to Beat George Osborne originally appeared on Fool.com.Tony owns shares in Vodafone, GlaxoSmithKline, Unilever, Reckitt Benckiser, BATS, and Shell. Motley Fool newsletter services have recommended buying shares of Vodafone Group and Unilever. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.